Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice.
about
Complement activation is required for induction of a protective antibody response against West Nile virus infectionAdditive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc Receptor-Dependent and -Independent MechanismsCharacterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis.Flavivirus nonstructural protein NS1: Complementary surprisesGenetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulationPre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse modelImmunization with nonstructural proteins promotes functional recovery of alphavirus-infected neuronsType- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent EpitopesNaked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challengeImmunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitisProtection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing)Virus-Specific Cytolytic Antibodies to Nonstructural Protein 1 of Japanese Encephalitis Virus Effect Reduction of Virus Output from Infected CellsThe Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1Evasion of innate and adaptive immunity by flavivirusesIssues related to recent dengue vaccine development.Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus.Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccinesHow to approach and treat viral infections in ICU patientsCD8+ T cells complement antibodies in protecting against yellow fever virus.Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine.Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation.Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model.Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms.Protective efficacy of nonneutralizing monoclonal antibodies in acute infection with murine leukemia virus.Dengue vaccine: priorities and progress.Yellow fever vaccine.Japanese encephalitis: development of new candidate vaccines.Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.Biomarkers in Japanese encephalitis: a review.IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.Clinical development of IMOJEV ®--a recombinant Japanese encephalitis chimeric vaccine (JE-CV).Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.A short N-terminal peptide motif on flavivirus nonstructural protein NS1 modulates cellular targeting and immune recognition.A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from diseaseHigh-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model.Complete genome sequence of Xishuangbanna flavivirus, a novel mosquito-specific flavivirus from China.Innate Immune Evasion Mediated by Flaviviridae Non-Structural Proteins.
P2860
Q27469834-68DD0FF5-DEDC-49EA-A11D-B489C70AB50CQ27469855-65D5B03D-36F7-401C-B272-7FB46FECC90CQ27472823-9DEA0E7A-56AB-4143-A95E-F2E1B0E2655CQ27473070-F3BAFDC2-C055-4159-ADCE-9EEBE534ACE0Q27477914-27D11A96-CCFB-45D9-8F42-321B1419E692Q27480770-6CC8F360-19C3-48D1-AD6E-F82E2F88F4F1Q27480808-603CFC0C-2EF4-4BDB-94E8-7010566DEE24Q27480814-B00C3BA1-3D86-4E70-9647-A4B376ADA1DFQ27485031-ABA51E8F-BD50-4E4C-A495-FAF25B6D83DEQ27485866-78DCD614-179A-4E2B-91E1-A33E80AD70E9Q27486490-8EB0724C-1C8D-4D47-A794-911FAA02BD1DQ27486827-C4309331-C876-4B53-97BE-032E3B6CC7E6Q27486833-58D122A9-2377-498B-935C-73D3F4C9D7F5Q27488397-E817F20F-234E-4A68-BC1D-0E68BBF29987Q27491317-50F3061B-EE50-4B3B-98D9-9A2355975C62Q28204656-071D1A2F-6A54-4536-B666-D1DF45C335D3Q30395396-05F50927-251F-45D8-930A-1B6D05627A1CQ33201423-2CC46A6E-6BA7-4CA9-BEC8-4B6CE7F10E02Q33800760-57AEA2CE-2903-4254-9CD2-53079A077B6EQ34057711-A64AB74A-5517-4FE7-A1A6-34D62462AEECQ34894660-093FA749-7E07-4215-AB24-E8A0E286B664Q34980404-9A823D6D-7249-411F-8B1F-4C8C5FAEB190Q35058245-0F2F1B2F-575E-4521-B87C-F11DCE35A0D9Q35058899-1863C3B3-A5B5-4921-85FA-EA34369150DDQ35141448-DBC3768C-CD81-481D-8C53-3E4D2846E804Q35531167-D6ECEEC2-3DE0-4318-B701-10F6825F924BQ35851163-65632610-CBDC-4089-B127-0C7C98BD7F82Q35964754-72661A79-E9F3-4DBD-A513-B25C65371953Q36238729-43B41130-D74B-472C-890D-317961A66275Q36441519-F3F3B39E-62E9-4FE0-B12B-262159C0DC33Q36825107-101D1456-6552-4562-A2B4-7FBDE90899DCQ37425963-ECC2C835-0086-462A-960E-49C1E27DA92CQ37812123-34677D4F-3259-4FC1-8AC1-6BD99446CECCQ38024857-C5542E4B-5B88-4227-89BE-E5A346EA0E9CQ39142065-AC104D56-E5F3-4AAB-AC98-D3FEBEEF4ABBQ39686453-6752C8B7-E15F-4E75-AEB3-E491DE7E5AA0Q39811978-E4C11A01-1024-405E-B38C-F97434B051F6Q40308632-09B026AE-1F4D-4073-8A4D-99B1EA459DBBQ40746350-FEDACCE0-B3A9-4445-BAD4-12B535F20C36Q41921678-D76A40D5-1E8D-4A58-8BD6-4E50CF5C4C1A
P2860
Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Neutralizing (54K) and non-neu ...... teins confer immunity in mice.
@en
type
label
Neutralizing (54K) and non-neu ...... teins confer immunity in mice.
@en
prefLabel
Neutralizing (54K) and non-neu ...... teins confer immunity in mice.
@en
P2093
P1476
Neutralizing (54K) and non-neu ...... teins confer immunity in mice.
@en
P2093
P304
P356
10.1099/0022-1317-67-3-591
P407
P478
67 ( Pt 3)
P577
1986-03-01T00:00:00Z